Publicaciones en las que colabora con Daniel Rueda (8)

2006

  1. Endocannabinoids: A new family of lipid mediators involved in the regulation of neural cell development

    Current Pharmaceutical Design, Vol. 12, Núm. 18, pp. 2319-2325

2002

  1. Mechanism of extracellular signal-regulated kinase activation by the CB1 cannabinoid receptor

    Molecular Pharmacology, Vol. 62, Núm. 6, pp. 1385-1392

  2. The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway

    Journal of Biological Chemistry, Vol. 277, Núm. 48, pp. 46645-46650

2001

  1. Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor

    Cancer Research, Vol. 61, Núm. 15, pp. 5784-5789

  2. The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan

    Molecular Pharmacology, Vol. 59, Núm. 5, pp. 955-959

2000

  1. The CB1 cannabinoid receptor is coupled to the activation of c-jun N-terminal kinase

    Molecular Pharmacology, Vol. 58, Núm. 4, pp. 814-820

1999

  1. Involvement of the cAMP/protein kinase A pathway and of mitogen- activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

    FEBS Letters, Vol. 463, Núm. 3, pp. 235-240

1998

  1. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Δ9-Tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes

    Molecular Pharmacology, Vol. 54, Núm. 5, pp. 834-843